This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. Check our privacy policy here.
R&D Portfolio
Organic chemistry has many applications and our participation in innovative R&D projects allows us to explore new chemistries and technologies. Through these collaborations, we have broadened our expertise in nanoparticle linkers, optical and electronic materials, biocatalysis, agrochemicals, food additives, porous frameworks, cosmetics, biosynthesis, and of course drug development.
PRECINMAS: Pre-candidates with new mechanisms of action against invasive non-typhoidal Salmonella
2025 - 2028
NUCAPCURE: New proton and neutron therapies with high cancer specificity by ‘hijacking’ haem biosynthesis
2024 - 2028
MAOPROST: Novel MAO-A Inhibitors for the Treatment of Castration-Resistant Prostate Cancer
2022 - 2025
ECM-CART: LDL-like nanoparticles for CAR-T-based glioblastoma immunotherapy
2022 - 2024
BioTICfinder: Second-generation diagnostic and therapeutic solutions for SARS-CoV-2
2021 - 2023
SHIKIFACTORY100: Modular factories for the production of 100 compounds from the SHIKIMATE pathway
2019 - 2023
DROUGHTDRUGS: A Drug Discovery Approach to Improve Drought Resistance in Crop Plants
2018 - 2021
IO4COLON: Industrial research for the discovery of new immunotherapeutic drugs in the treatment of colon cancer
2018 - 2020
INLUNG: New drug candidates for non-small cell lung cancer treatment
2018 - 2020
BIOGREEN: Innovative technological solutions for the development of a biorefinery model based on green biomass
2016 - 2019
NANOFACTURING: Medium- and large-scale manufacturing platforms for clinically compliant nanopharmaceuticals
2015 - 2019
NEOGALFARM: Development of therapies and combined treatments directed at different therapeutic targets
2016 - 2018